Maravai Lifesciences Holdings (MRVI) EBT Growth (1y) (2021 - 2026)
Maravai Lifesciences Holdings (MRVI) EBT Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -88.68% |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 13.34% |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -51.60% |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -313.33% |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -79.57% |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -230.18% |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 71.54% |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Maravai Lifesciences Holdings | 727.74 Mn | 719.33 Mn | 33.70 Mn | 87.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 87.61% |
| Dec 31, 2025 | -36.76% |
| Sep 30, 2025 | 73.77% |
| Jun 30, 2025 | -255.43% |
| Mar 31, 2025 | -135.13% |
| Dec 31, 2024 | -107.02% |
| Sep 30, 2024 | -737.15% |
| Jun 30, 2024 | -56.05% |
| Mar 31, 2024 | -395.45% |
| Dec 31, 2023 | 584.41% |
| Sep 30, 2023 | -118.08% |
| Jun 30, 2023 | -107.64% |
| Mar 31, 2023 | -102.71% |
| Dec 31, 2022 | -33.74% |
| Sep 30, 2022 | -24.67% |
| Jun 30, 2022 | 19.95% |
| Mar 31, 2022 | 87.10% |
| Dec 31, 2021 | 874.93% |
| Sep 30, 2021 | 290.59% |
| Jun 30, 2021 | 21,448.45% |